{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 75,
        "end": 85
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 88,
        "end": 93
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 99,
        "end": 108
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 111,
        "end": 119
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 125,
        "end": 129
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 35,
        "end": 46
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 49,
        "end": 58
      }
    },
    {
      "id": "T9",
      "obj": "Disease",
      "span": {
        "begin": 125,
        "end": 161
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 35,
        "end": 95
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "12419746_1",
  "text": "In vitro comparative evaluation of trastuzumab ( Herceptin ) combined with paclitaxel ( Taxol ) or docetaxel ( Taxotere ) in HER2 -expressing human breast cancer cell lines ."
}
